Analyst Price Target is $79.92
▲ +36.80% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $79.92, with a high forecast of $93.00 and a low forecast of $52.00. The average price target represents a 36.80% upside from the last price of $58.42.
Current Consensus is
Moderate Buy
The current consensus among 15 contributing investment analysts is to moderate buy stock in Centene. This rating has held steady since October 2024, when it changed from a Hold consensus rating.
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Read More